Latest news

Search
Categories
News archive

Nanologica AB Informs that Flerie Invest AB has Passed the Threshold for Mandatory Bid

26 April, 2025

Nanologica’s main owner Flerie Invest AB (“Flerie”) has acquired additional shares in Nanologica AB with the result that a mandatory bid obligation has arisen. Flerie’s total holding in Nanologica after the acquisition amounts to 38,222,779 shares, which corresponds to approximately 43.26 percent of the total number of shares and votes in the company. According to the Swedish Securities Council’s statement AMN 2024:62, Flerie was granted an exemption from the obligation to make a mandatory bid

Read more »

Nanologica AB Receives Order Worth USD 180,000 from New Customer in China

23 April, 2025

Nanologica has received an order for the company’s silica-based purification media NLAB Saga® from a new customer in China. The customer is a large pharmaceutical manufacturer, and the order relates to evaluation of NLAB Saga® on a production scale. The order, which is worth USD 180,000, will be delivered during the second quarter. ”This is a highly interesting customer for us as it is larger than some of the others we work with. Among other

Read more »

Interim Report Q1 2025

16 April, 2025

FINANCIAL SUMMARY Net sales for the first quarter amounted to SEK 10,751 thousand (5,037) The operating loss amounted to SEK 9,241 thousand (15,331) Loss after tax amounted to SEK 10,171 thousand (16,734) Earnings per share before and after dilution were SEK -0.12 (-0.46) Cash and cash equivalents per 31 March 2024 amounted to SEK 28,348 thousand (23,600). Shortly after the end of the quarter, the company’s cash and cash equivalents increased by approximately SEK 7

Read more »